These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17574425)

  • 1. The effect of the [18F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety--an EGFR putative irreversible inhibitor.
    Dissoki S; Aviv Y; Laky D; Abourbeh G; Levitzki A; Mishani E
    Appl Radiat Isot; 2007 Oct; 65(10):1140-51. PubMed ID: 17574425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors.
    Mishani E; Abourbeh G; Jacobson O; Dissoki S; Ben Daniel R; Rozen Y; Shaul M; Levitzki A
    J Med Chem; 2005 Aug; 48(16):5337-48. PubMed ID: 16078851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors.
    Mishani E; Abourbeh G; Rozen Y; Jacobson O; Laky D; Ben David I; Levitzki A; Shaul M
    Nucl Med Biol; 2004 May; 31(4):469-76. PubMed ID: 15093817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis of 1-[18F]fluoroethyl-L-tryptophan as a novel potential amino acid PET tracer.
    Sun T; Tang G; Tian H; Wang X; Chen X; Chen Z; Wang S
    Appl Radiat Isot; 2012 Apr; 70(4):676-80. PubMed ID: 22196677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
    Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4819-23. PubMed ID: 16139501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2.
    Wissner A; Fraser HL; Ingalls CL; Dushin RG; Floyd MB; Cheung K; Nittoli T; Ravi MR; Tan X; Loganzo F
    Bioorg Med Chem; 2007 Jun; 15(11):3635-48. PubMed ID: 17416531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and biological evaluation of
    Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer.
    Shaul M; Abourbeh G; Jacobson O; Rozen Y; Laky D; Levitzki A; Mishani E
    Bioorg Med Chem; 2004 Jul; 12(13):3421-9. PubMed ID: 15186828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies.
    Guenther KJ; Yoganathan S; Garofalo R; Kawabata T; Strack T; Labiris R; Dolovich M; Chirakal R; Valliant JF
    J Med Chem; 2006 Feb; 49(4):1466-74. PubMed ID: 16480283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated synthesis of [18F]gefitinib on a modular system.
    Läppchen T; Vlaming ML; Custers E; Lub J; Sio CF; DeGroot J; Steinbach OC
    Appl Radiat Isot; 2012 Jan; 70(1):205-9. PubMed ID: 21975107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel
    Chong Y; Chang J; Zhao W; He Y; Li Y; Zhang H; Qi C
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):42-53. PubMed ID: 28833405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents.
    Neto C; Fernandes C; Oliveira MC; Gano L; Mendes F; Kniess T; Santos I
    Nucl Med Biol; 2012 Feb; 39(2):247-60. PubMed ID: 22079040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of fluorine-18 labeled diaryl ureas--labeled VEGFR-2/PDGFR dual inhibitors as molecular imaging agents for angiogenesis.
    Ilovich O; Jacobson O; Aviv Y; Litchi A; Chisin R; Mishani E
    Bioorg Med Chem; 2008 Apr; 16(8):4242-51. PubMed ID: 18343125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
    Matsuno K; Ushiki J; Seishi T; Ichimura M; Giese NA; Yu JC; Takahashi S; Oda S; Nomoto Y
    J Med Chem; 2003 Nov; 46(23):4910-25. PubMed ID: 14584942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and inhibitory activity of 4-alkynyl and 4-alkenylquinazolines: identification of new scaffolds for potent EGFR tyrosine kinase inhibitors.
    Kitano Y; Suzuki T; Kawahara E; Yamazaki T
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5863-7. PubMed ID: 17869510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynthesis of F-18 labeled cytidine analog 2'-fluoro-5-iodo-l-beta-d-arabinofuranosylcytosine ([(18)F]FIAC).
    Wu CY; Chan PC; Chang WT; Liu RS; Alauddin MM; Wang HE
    Appl Radiat Isot; 2009; 67(7-8):1362-5. PubMed ID: 19324560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging.
    Bourkoula A; Paravatou-Petsotas M; Papadopoulos A; Santos I; Pietzsch HJ; Livaniou E; Pelecanou M; Papadopoulos M; Pirmettis I
    Eur J Med Chem; 2009 Oct; 44(10):4021-7. PubMed ID: 19487055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhenium and technetium complexes bearing quinazoline derivatives: progress towards a 99mTc biomarker for EGFR-TK imaging.
    Fernandes C; Santos IC; Santos I; Pietzsch HJ; Kunstler JU; Kraus W; Rey A; Margaritis N; Bourkoula A; Chiotellis A; Paravatou-Petsotas M; Pirmettis I
    Dalton Trans; 2008 Jun; (24):3215-25. PubMed ID: 18688420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.